DNA X financials
$4.19−3.68%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $93.6M | $69.8M | $54.6M | $64.0M | $116.3M |
| Gross profit | $0.00 | $0.00 | $19.3M | $11.6M | $6.4M | $15.2M | $34.5M |
| Gross margin | — | — | 20.6% | 16.6% | 11.8% | 23.8% | 29.7% |
| Operating income | -$5.4M | -$3.1M | $513.0K | -$14.3M | -$38.0M | -$29.3M | -$22.4M |
| Net income | -$20.7M | -$33.6M | -$90.0K | -$14.1M | -$38.6M | -$29.9M | -$25.8M |
| Net margin | — | — | −0.1% | −20.2% | −70.8% | −46.8% | −22.2% |
| Diluted EPS | $-28.58 | $-128.37 | $-0.36 | $-88.20 | $-734.40 | $-1166.40 | $-2502.00 |
| EBITDA | -$1.1M | $457.0K | $2.7M | -$11.9M | -$35.9M | -$25.0M | -$18.1M |
| Operating cash flow | -$23.5M | -$8.5M | -$4.1M | -$12.4M | -$38.5M | -$10.6M | -$33.5M |
| Free cash flow | -$23.5M | -$8.7M | -$4.1M | -$12.4M | -$38.5M | -$10.6M | -$34.9M |
| Diluted shares | 0.7M | 0.3M | 0.2M | 0.2M | 0.1M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.3M | $5.3M | $9.4M | $13.2M | $11.2M | $22.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $5.1M | $0.00 | $0.00 | $147.0K | $148.0K | $362.0K |
| Total assets | $43.9M | $39.7M | $56.0M | $53.7M | $41.1M | $50.3M |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M | $21.9M |
| Shareholders' equity | -$6.7M | -$5.7M | $22.4M | $20.0M | $18.6M | $28.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology